{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T22:31:34Z","timestamp":1768084294202,"version":"3.49.0"},"reference-count":166,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T00:00:00Z","timestamp":1563494400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["201507720015"],"award-info":[{"award-number":["201507720015"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["022005019"],"award-info":[{"award-number":["022005019"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004243","name":"Prinses Beatrix Spierfonds","doi-asserted-by":"publisher","award":["WAR08-12"],"award-info":[{"award-number":["WAR08-12"]}],"id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.autrev.2019.102348","type":"journal-article","created":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T19:40:59Z","timestamp":1563306059000},"page":"102348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Autoimmunity in psychotic disorders. Where we stand, challenges and opportunities"],"prefix":"10.1016","volume":"18","author":[{"given":"Marina","family":"Man\u00e9-Damas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolin","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenghua","family":"Zong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter C.","family":"Molenaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Losen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Martinez-Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2019.102348_bb0005","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.neubiorev.2011.11.005","article-title":"Abnormalities in thalamic neurophysiology in schizophrenia: could psychosis be a result of potassium channel dysfunction","volume":"36","author":"Vukadinovic","year":"2012","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.autrev.2019.102348_bb0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.schres.2011.01.021","article-title":"Altered levels of glutamatergic receptors and Na+\/K+ ATPase-alpha1 in the prefrontal cortex of subjects with schizophrenia","volume":"128","author":"Corti","year":"2011","journal-title":"Schizophr Res"},{"key":"10.1016\/j.autrev.2019.102348_bb0015","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.biopsych.2005.10.005","article-title":"Synaptic plasticity and dysconnection in schizophrenia","volume":"59","author":"Stephan","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.autrev.2019.102348_bb0020","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41573-019-0013-8","article-title":"Antibodies and venom peptides: new modalities for ion channels","volume":"18","author":"Wulff","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.autrev.2019.102348_bb0025","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11920-015-0570-4","article-title":"Neurology issues in schizophrenia","volume":"17","author":"H\u00fcfner","year":"2015","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.autrev.2019.102348_bb0030","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0140-6736(12)62129-1","article-title":"Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis","volume":"381","author":"Smoller","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2019.102348_bb0035","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00439-011-0975-z","article-title":"Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia","volume":"130","author":"Gauthier","year":"2011","journal-title":"Hum Genet"},{"key":"10.1016\/j.autrev.2019.102348_bb0040","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/hmg\/ddn351","article-title":"Disruption of the neurexin 1 gene is associated with schizophrenia","volume":"18","author":"Rujescu","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.autrev.2019.102348_bb0045","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neulet.2006.08.017","article-title":"High frequency of neurexin 1\u03b2 signal peptide structural variants in patients with autism","volume":"409","author":"Feng","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.autrev.2019.102348_bb0050","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jpsychires.2011.10.015","article-title":"Mutation analysis of the NRXN1 gene in a Chinese autism cohort","volume":"46","author":"Liu","year":"2012","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.autrev.2019.102348_bb0055","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ajhg.2011.11.025","article-title":"Rare deletions at the neurexin 3 locus in autism spectrum disorder","volume":"90","author":"Vaags Andrea","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.autrev.2019.102348_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(00)00022-0","article-title":"Schizophrenia and HLA: a review","volume":"47","author":"Wright","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1016\/j.autrev.2019.102348_bb0065","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1601-183X.2011.00710.x","article-title":"Comparative immunogenetics of autism and schizophrenia","volume":"10","author":"Crespi","year":"2011","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.autrev.2019.102348_bb0070","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2019.102348_bb0075","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/archneurpsyc.1959.02340150095011","article-title":"Study of a new schizophrenomimetic drug\u2014sernyl","volume":"81","author":"Luby","year":"1959","journal-title":"Arch Neurol Psychiatr"},{"key":"10.1016\/j.autrev.2019.102348_bb0080","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archpsyc.1995.03950240016004","article-title":"Glutamate receptor dysfunction and schizophrenia","volume":"52","author":"Olney","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.autrev.2019.102348_bb0085","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0893-133X(95)00137-3","article-title":"NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers","volume":"14","author":"Malhotra","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.autrev.2019.102348_bb0090","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0006-3223(96)00546-X","article-title":"Clozapine blunts N-methyl-d-aspartate antagonist-induced psychosis: a study with ketamine","volume":"42","author":"Malhotra","year":"1997","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.autrev.2019.102348_bb0095","series-title":"Drugs & Drug Abuse: A Reference Text","author":"Bruna Brands","year":"1998"},{"key":"10.1016\/j.autrev.2019.102348_bb0100","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-2005-916185","article-title":"Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers","volume":"38","author":"Gouzoulis-Mayfrank","year":"2005","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.autrev.2019.102348_bb0105","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jaut.2009.09.008","article-title":"Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases","volume":"33","author":"Cooper","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2019.102348_bb0110","doi-asserted-by":"crossref","first-page":"a006908","DOI":"10.1101\/cshperspect.a006908","article-title":"Historical overview of immunological tolerance","volume":"4","author":"Schwartz","year":"2012","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.autrev.2019.102348_bb0115","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.autrev.2016.02.004","article-title":"Understanding autoimmunity: the ion channel perspective","volume":"15","author":"RamaKrishnan","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2019.102348_bb0120","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.autrev.2012.10.016","article-title":"Developments in autoimmune channelopathies","volume":"12","author":"Vincent","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2019.102348_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2019.102348_bb0130","first-page":"925","article-title":"Recombinant thyroid peroxidase-specific Fab converted to immunoglobulin G (IgG) molecules: evidence for thyroid cell damage by IgG1, but not IgG4, autoantibodies","volume":"82","author":"Guo","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2019.102348_bb0135","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cardfail.2016.03.005","article-title":"Autoantibodies specifically against \u03b21 adrenergic receptors and adverse clinical outcome in patients with chronic systolic heart failure in the \u03b2-blocker era: the importance of immunoglobulin G3 subclass","volume":"22","author":"Nagatomo","year":"2016","journal-title":"J Card Fail"},{"key":"10.1016\/j.autrev.2019.102348_bb0140","first-page":"5","article-title":"Pathogenesis of myasthenia gravis: update on disease types, models, and mechanisms","author":"Phillips","year":"2016","journal-title":"F1000Research"},{"key":"10.1016\/j.autrev.2019.102348_bb0145","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2222.2009.03207.x","article-title":"Immunoglobulin G4: an odd antibody","volume":"39","author":"Aalberse","year":"2009","journal-title":"Clin Exp Allerg J Br Soc Allerg Clin Immunol"},{"key":"10.1016\/j.autrev.2019.102348_bb0150","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1126\/science.1144603","article-title":"Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange","volume":"317","author":"van der Neut","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.autrev.2019.102348_bb0155","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1056\/NEJMoa043160","article-title":"Autoantibodies to folate receptors in the cerebral folate deficiency syndrome","volume":"352","author":"Ramaekers","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2019.102348_bb0160","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.4049\/jimmunol.1102592","article-title":"Brain human monoclonal autoantibody from sydenham chorea targets dopaminergic neurons in transgenic mice and signals dopamine D2 receptor: implications in human disease","volume":"191","author":"Cox","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2019.102348_bb0165","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/ana.23756","article-title":"Encephalitis and antibodies to DPPX, a subunit of Kv4.2 potassium channels","volume":"73","author":"Boronat","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2019.102348_bb0170","article-title":"Autoantibodies in the CSF of anti-GABA receptor encephalitis patients block activation of GABA receptors in vitro","volume":"78","author":"Jain Le","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2019.102348_bb0175","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","article-title":"Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen","volume":"9","author":"Lancaster","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2019.102348_bb0180","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis","volume":"30","author":"Hughes","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.autrev.2019.102348_bb0185","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/brain\/aws092","article-title":"Disrupted surface cross-talk between NMDA and ephrin-B2 receptors in anti-NMDA encephalitis","volume":"135","author":"Mikasova","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2019.102348_bb0190","doi-asserted-by":"crossref","first-page":"e1386","DOI":"10.1212\/WNL.0000000000005329","article-title":"Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor","volume":"90","author":"Hara","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2019.102348_bb0195","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/brain\/awu310","article-title":"Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice","volume":"138","author":"Planagum\u00e0","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2019.102348_bb0200","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.21589","article-title":"AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location","volume":"65","author":"Lai","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2019.102348_bb0205","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neuron.2018.07.048","article-title":"Human autoantibodies against the AMPA receptor subunit GluA2 induce receptor reorganization and memory dysfunction","volume":"100","author":"Haselmann","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.autrev.2019.102348_bb0210","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1474-4422(13)70299-0","article-title":"Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies","volume":"13","author":"Petit-Pedrol","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2019.102348_bb0215","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","article-title":"A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study","volume":"13","author":"Sabater","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2019.102348_bb0220","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1212\/WNL.0000000000002775","article-title":"Human neurexin-3\u03b1 antibodies associate with encephalitis and alter synapse development","volume":"86","author":"Gresa-Arribas","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2019.102348_bb0225","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1212\/01.wnl.0000327606.50322.f0","article-title":"Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody","volume":"71","author":"Hutchinson","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2019.102348_bb0230","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/08916930903555943","article-title":"Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction","volume":"43","author":"Gomez","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2019.102348_bb0235","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1074-7613(04)00112-8","article-title":"Pathogenic roles of B cells in human autoimmunity","volume":"20","author":"Martin","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2019.102348_bb0240","doi-asserted-by":"crossref","first-page":"7307","DOI":"10.1523\/JNEUROSCI.20-19-07307.2000","article-title":"GluR3 autoantibodies destroy neural cells in a complement-dependent manner modulated by complement regulatory proteins","volume":"20","author":"Whitney","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.autrev.2019.102348_bb0245","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/brain\/awu142","article-title":"Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes","volume":"137","author":"Carvajal-Gonz\u00e1lez","year":"2014","journal-title":"Brain J Neurol"},{"issue":"2","key":"10.1016\/j.autrev.2019.102348_bb0250","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1212\/NXI.0000000000000075","article-title":"Complement-associated neuronal loss in a patient with CASPR2 antibody-associated encephalitis","volume":"2","author":"K\u00f6rtvelyessy","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflam"},{"key":"10.1016\/j.autrev.2019.102348_bb0255","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/brain\/aws082","article-title":"Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis","volume":"135","author":"Bien","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2019.102348_bb0260","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1212\/WNL.0b013e318228c136","article-title":"Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis","volume":"77","author":"Martinez-Hernandez","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2019.102348_bb0265","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00401-009-0582-4","article-title":"Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma","volume":"118","author":"T\u00fcz\u00fcn","year":"2009","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.autrev.2019.102348_bb0270","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1152\/physrev.00010.2016","article-title":"Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system","volume":"97","author":"Dalmau","year":"2017","journal-title":"Physiol Rev"},{"key":"10.1016\/j.autrev.2019.102348_bb0275","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2019.102348_bb0280","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","article-title":"Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series","volume":"9","author":"Lai","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2019.102348_bb0285","doi-asserted-by":"crossref","first-page":"18161","DOI":"10.1523\/JNEUROSCI.3506-13.2013","article-title":"Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors","volume":"33","author":"Ohkawa","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.autrev.2019.102348_bb0290","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0092-8674(00)00197-5","article-title":"EphB receptors interact with NMDA receptors and regulate excitatory synapse formation","volume":"103","author":"Dalva","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2019.102348_bb0295","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0896-6273(01)00553-0","article-title":"The receptor tyrosine kinase EphB2 regulates NMDA-dependent synaptic function","volume":"32","author":"Henderson","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.autrev.2019.102348_bb0300","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrm856","article-title":"Mechanisms and functions of eph and ephrin signalling","volume":"3","author":"Kullander","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.autrev.2019.102348_bb0305","first-page":"5","article-title":"Eph receptor signaling and ephrins","author":"Lisabeth","year":"2013","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"10.1016\/j.autrev.2019.102348_bb0310","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1073\/pnas.91.12.5705","article-title":"Macromolecular permeability across the blood-nerve and blood-brain barriers","volume":"91","author":"Poduslo","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2019.102348_bb0315","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nri2529","article-title":"Losing your nerves? Maybe it's the antibodies","volume":"9","author":"Diamond","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2019.102348_bb0320","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1750-1172-2-22","article-title":"Paraneoplastic neurological syndromes","volume":"2","author":"Honnorat","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.autrev.2019.102348_bb0325","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2019.102348_bb0330","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1056\/NEJM198804213181602","article-title":"Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus","volume":"318","author":"Solimena","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2019.102348_bb0335","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jneuroim.2009.04.010","article-title":"Autoantibodies to glutamic acid decarboxylase (GAD) in focal and generalized epilepsy: a study on 233 patients","volume":"211","author":"Errichiello","year":"2009","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2019.102348_bb0340","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1172\/JCI41366","article-title":"Elevated tribbles homolog 2-specific antibody levels in narcolepsy patients","volume":"120","author":"Cvetkovic-Lopes","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2019.102348_bb0345","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0165-5728(02)00226-6","article-title":"Maternal antibody-mediated dyslexia? Evidence for a pathogenic serum factor in a mother of two dyslexic children shown by transfer to mice using behavioural studies and magnetic resonance spectroscopy","volume":"130","author":"Vincent","year":"2002","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2019.102348_bb0350","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2019.102348_bb0355","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0022-510X(70)90154-1","article-title":"The origin and turnover rates of cerebrospinal fluid albumin and gamma-globulin in man","volume":"10","author":"Cutler","year":"1970","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2019.102348_bb0360","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1192\/bjp.139.6.513","article-title":"Quantitative determination of immunoglobulins in CSF and plasma of chronic schizophrenic patients","volume":"139","author":"Delisi","year":"1981","journal-title":"Br J Psychiatry: J Mental Sci"},{"key":"10.1016\/j.autrev.2019.102348_bb0365","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","article-title":"Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study","volume":"13","author":"Gresa-Arribas","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2019.102348_bb0370","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fnhum.2015.00476","article-title":"Immunological findings in psychotic syndromes: a tertiary care hospital's CSF sample of 180 patients","volume":"9","author":"Endres","year":"2015","journal-title":"Front Human Neurosci"},{"key":"10.1016\/j.autrev.2019.102348_bb0375","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatics","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2019.102348_bb0380","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ana.24083","article-title":"Herpes simplex virus encephalitis is a trigger of brain autoimmunity","volume":"75","author":"Armangue","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2019.102348_bb0385","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.0000000000002125","article-title":"Autoimmune post\u2013herpes simplex encephalitis of adults and teenagers","volume":"85","author":"Armangue","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2019.102348_bb0390","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1093\/brain\/aww208","article-title":"Human cerebrospinal fluid monoclonal N -methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis","volume":"139","author":"Kreye","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2019.102348_bb0395","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1212\/WNL.0000000000000126","article-title":"Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis","volume":"82","author":"Viaccoz","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2019.102348_bb0400","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jamaneurol.2014.2956","article-title":"Investigations on CXCL13 in anti\u2013N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response","volume":"72","author":"Leypoldt","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.autrev.2019.102348_bb0405","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2004.07.011","article-title":"Cognition and immunity: antibody impairs memory","volume":"21","author":"Kowal","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2019.102348_bb0410","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1073\/pnas.0510055103","article-title":"Immunity and behavior: antibodies alter emotion","volume":"103","author":"Huerta","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2019.102348_bb0415","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/jnnp-2012-303807","article-title":"Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens","volume":"84","author":"Hacohen","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2019.102348_bb0420","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jamaneurol.2013.592","article-title":"Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping","volume":"70","author":"Klein","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.autrev.2019.102348_bb0425","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1136\/jnnp-2015-313000","article-title":"Emerging psychiatric syndromes associated with antivoltage-gated potassium channel complex antibodies","volume":"87","author":"Pruss","year":"2016","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.autrev.2019.102348_bb0430","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(11)60548-5","article-title":"Late onset autism and anti-NMDA-receptor encephalitis","volume":"378","author":"Creten","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2019.102348_bb0435","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jamaneurol.2013.3216","article-title":"Frequency and characteristics of isolated psychiatric episodes in anti-N-methyl-d-aspartate receptor encephalitis","volume":"70","author":"Kayser","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.autrev.2019.102348_bb0440","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.2147\/NDT.S82380","article-title":"Autoimmune encephalitis in psychiatric institutions: current perspectives","volume":"12","author":"Bost","year":"2016","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.autrev.2019.102348_bb0445","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1176\/appi.ajp.2010.10020181","article-title":"Anti-NMDA receptor encephalitis: diagnosis, psychiatric presentation, and treatment","volume":"168","author":"Chapman","year":"2011","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.autrev.2019.102348_bb0450","first-page":"253891","article-title":"Anti-NMDA receptor encephalitis in a patient with previous psychosis and neurological abnormalities: a diagnostic challenge","volume":"2015","author":"Heekin","year":"2015","journal-title":"Case Rep Psychiatr"},{"key":"10.1016\/j.autrev.2019.102348_bb0455","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1212\/WNL.0b013e3182a35271","article-title":"GABA(B) receptor autoantibody frequency in service serologic evaluation","volume":"81","author":"Jeffery","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2019.102348_bb0460","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1176\/appi.neuropsych.14030066","article-title":"Anti\u2013N-methyl-d-aspartate receptor encephalitis presenting with psychiatric symptoms","volume":"27","author":"Mangalwedhe","year":"2015","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.autrev.2019.102348_bb0465","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s00415-010-5788-9","article-title":"Disease-relevant autoantibodies in first episode schizophrenia","volume":"258","author":"Zandi","year":"2011","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2019.102348_bb0470","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S2215-0366(16)30375-3","article-title":"Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: a case-control study","volume":"4","author":"Lennox","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.autrev.2019.102348_bb0475","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ana.24189","article-title":"Seroprevalence of autoantibodies against brain antigens in health and disease","volume":"76","author":"Dahm","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2019.102348_bb0480","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.schres.2017.04.027","article-title":"Anti-neuronal anti-bodies in patients with early psychosis","author":"Mantere","year":"2018","journal-title":"Schizophr Res"},{"key":"10.1016\/j.autrev.2019.102348_bb0485","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.schres.2017.03.012","article-title":"Seroprevalence survey of selective anti-neuronal autoantibodies in patients with first-episode schizophrenia and chronic schizophrenia","volume":"190","author":"Chen","year":"2017","journal-title":"Schizophr Res"},{"key":"10.1016\/j.autrev.2019.102348_bb0490","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s00415-014-7588-0","article-title":"An 11-year retrospective experience of antibodies against the voltage-gated potassium channel (VGKC) complex from a tertiary neurological centre","volume":"262","author":"Huda","year":"2015","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2019.102348_bb0495","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/jnnp-2013-305218","article-title":"Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre","volume":"85","author":"Paterson","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2019.102348_bb0500","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jamaneurol.2013.592","article-title":"Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtypingLGI1 and CASPR2 VGKC complex autoantibodies","volume":"70","author":"Klein","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.autrev.2019.102348_bb0505","first-page":"1","article-title":"Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis","author":"Steiner","year":"2013","journal-title":"JAMA Psychiatr"},{"key":"10.1016\/j.autrev.2019.102348_bb0510","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/mp.2013.110","article-title":"Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity","volume":"19","author":"Hammer","year":"2014","journal-title":"Mol Psychiatr"},{"key":"10.1016\/j.autrev.2019.102348_bb0515","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1017\/S0033291716002038","article-title":"Prevalence of serum anti-neuronal autoantibodies in patients admitted to acute psychiatric care","volume":"46","author":"Schou","year":"2016","journal-title":"Psychol Med"},{"key":"10.1016\/j.autrev.2019.102348_bb0520","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bbi.2016.03.011","article-title":"Anti-NMDAR antibodies in new-onset psychosis. Positive results in an HIV-infected patient","volume":"56","author":"Arboleya","year":"2016","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.autrev.2019.102348_bb0525","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.biopsych.2017.06.015","article-title":"Cell- and single molecule-based methods to detect anti-N-methyl-D-aspartate receptor autoantibodies in patients with first-episode psychosis from the OPTiMiSE project","volume":"82","author":"J\u00e9z\u00e9quel","year":"2017","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.autrev.2019.102348_bb0530","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1176\/appi.ajp.2012.12050646","article-title":"Serum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in schizophrenia","volume":"169","author":"Masdeu","year":"2012","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.autrev.2019.102348_bb0535","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1001\/jamapsychiatry.2015.0526","article-title":"Absence of N-methyl-D-aspartate receptor IgG autoantibodies in schizophrenia: the importance of cross-validation studies","volume":"72","author":"de Witte","year":"2015","journal-title":"JAMA Psychiatr"},{"key":"10.1016\/j.autrev.2019.102348_bb0540","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.schres.2017.03.012","article-title":"Seroprevalence survey of selective anti-neuronal autoantibodies in patients with first-episode schizophrenia and chronic schizophrenia","volume":"190","author":"Chen","year":"2017","journal-title":"Schizophr Res"},{"key":"10.1016\/j.autrev.2019.102348_bb0545","first-page":"1","article-title":"Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders. The","author":"Oviedo-Salcedo","year":"2018","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.autrev.2019.102348_bb0550","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.biopsych.2014.07.014","article-title":"Antibodies to surface dopamine-2 receptor and N-methyl-D-aspartate receptor in the first episode of acute psychosis in children","volume":"77","author":"Pathmanandavel","year":"2015","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.autrev.2019.102348_bb0555","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1192\/bjp.bp.113.142216","article-title":"Prevalence of serum N-methyl-D-aspartate receptor autoantibodies in refractory psychosis","volume":"206","author":"Beck","year":"2015","journal-title":"Br J Psychiatry: J Mental Sci"},{"key":"10.1016\/j.autrev.2019.102348_bb0560","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1176\/appi.ajp.2015.14101332","article-title":"Autoimmune encephalitis in postpartum psychosis","volume":"172","author":"Bergink","year":"2015","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.autrev.2019.102348_bb0565","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/jnnp-2016-315251","article-title":"CASPR2 autoantibodies are raised during pregnancy in mothers of children with mental retardation and disorders of psychological development but not autism","volume":"88","author":"Coutinho","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2019.102348_bb0570","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/00004583-199011000-00005","article-title":"Detection of maternal antibodies in infantile autism","volume":"29","author":"Warren","year":"1990","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.autrev.2019.102348_bb0575","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1196\/annals.1254.036","article-title":"Antibodies in myasthenia gravis and related disorders","volume":"998","author":"Vincent","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2019.102348_bb0580","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/ana.10557","article-title":"Maternal neuronal antibodies associated with autism and a language disorder","volume":"53","author":"Dalton","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2019.102348_bb0585","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.bbi.2007.12.007","article-title":"Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism","volume":"22","author":"Martin","year":"2008","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.autrev.2019.102348_bb0590","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.psym.2015.01.003","article-title":"Psychiatric autoimmunity: N-methyl-d-aspartate receptor IgG and beyond","volume":"56","author":"Kruse","year":"2015","journal-title":"Psychosomatics"},{"key":"10.1016\/j.autrev.2019.102348_bb0595","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s10072-014-1966-3","article-title":"A case of NMDAR encephalitis misdiagnosed as postpartum psychosis and neuroleptic malignant syndrome","volume":"36","author":"Keskek","year":"2015","journal-title":"Neurol Sci"},{"key":"10.1016\/j.autrev.2019.102348_bb0600","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1590\/1980-57642015dn93000016","article-title":"A patient with a long history of relapsing psychosis and mania presenting with anti-NMDA receptor encephalitis ten years after first episode","volume":"9","author":"Simabukuro","year":"2015","journal-title":"Dement Neuropsychol"},{"key":"10.1016\/j.autrev.2019.102348_bb0605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17843286.2017.1392077","article-title":"Anti-NMDA receptor encephalitis: still unknown and underdiagnosed by physicians and especially by psychiatrists","author":"Hermans","year":"2017","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.autrev.2019.102348_bb0610","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/PRA.0000000000000266","article-title":"Voltage-gated potassium channel antibody autoimmune encephalopathy presenting with isolated psychosis in an adolescent","volume":"23","author":"Kahn","year":"2017","journal-title":"J Psychiatr Pract"},{"key":"10.1016\/j.autrev.2019.102348_bb0615","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/PRA.0000000000000265","article-title":"Voltage-gated potassium channel antibody autoimmune encephalopathy presenting with isolated psychosis in an adolescent","volume":"23","author":"Pon","year":"2017","journal-title":"J Psychiatr Pract"},{"key":"10.1016\/j.autrev.2019.102348_bb0620","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neures.2009.01.002","article-title":"Schizophrenia and epilepsy: is there a shared susceptibility","volume":"63","author":"Cascella","year":"2009","journal-title":"Neurosci Res"},{"key":"10.1016\/j.autrev.2019.102348_bb0625","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1471-244X-14-75","article-title":"The prevalence of psychosis in epilepsy; a systematic review and meta-analysis","volume":"14","author":"Clancy","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.autrev.2019.102348_bb0630","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00406-013-0436-x","article-title":"Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions","volume":"264","author":"Schoepf","year":"2014","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.autrev.2019.102348_bb0635","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/PRA.0000000000000100","article-title":"A case of anti-NMDA receptor encephalitis treated with ECT","volume":"21","author":"Jones","year":"2015","journal-title":"J Psychiatr Pract"},{"key":"10.1016\/j.autrev.2019.102348_bb0640","doi-asserted-by":"crossref","first-page":"E32","DOI":"10.1176\/jnp.23.2.jnpe32","article-title":"Voltage-gated, potassium-channel antibody-associated limbic encephalitis presenting as acute psychosis","volume":"23","author":"Amitava","year":"2011","journal-title":"J Neuropsychiatr Clin Neurosci"},{"key":"10.1016\/j.autrev.2019.102348_bb0645","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jns.2011.06.017","article-title":"Limbic encephalitis presenting as a post-partum psychiatric condition","volume":"308","author":"Gotkine","year":"2011","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2019.102348_bb0650","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/archneurol.2010.133","article-title":"Anti\u2013N-methyl-d-aspartate receptor encephalitis during pregnancy","volume":"67","author":"Kumar","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2019.102348_bb0655","doi-asserted-by":"crossref","first-page":"421","DOI":"10.5144\/0256-4947.2012.421","article-title":"Anti-NMDA-receptor encephalitis presenting as postpartum psychosis in a young woman, treated with rituximab","volume":"32","author":"Shaaban","year":"2012","journal-title":"Ann Saudi Med"},{"key":"10.1016\/j.autrev.2019.102348_bb0660","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.psym.2011.01.043","article-title":"Paraneoplastic encephalitis presenting as postpartum psychosis","volume":"52","author":"Yu","year":"2011","journal-title":"Psychosomatics"},{"key":"10.1016\/j.autrev.2019.102348_bb0665","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ana.25131","article-title":"Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis","volume":"83","author":"Divyanshu","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2019.102348_bb0670","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.autrev.2009.01.013","article-title":"Clinical performance characteristics of a laboratory test. A practical approach in the autoimmune laboratory","volume":"8","author":"Bossuyt","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2019.102348_bb0675","series-title":"Book Clinical interpretation of laboratory procedures","first-page":"192","article-title":"Clinical interpretation of laboratory procedures","author":"Shultz","year":"1996"},{"key":"10.1016\/j.autrev.2019.102348_bb0680","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ana.24545","article-title":"The brain as immunoprecipitator of serum autoantibodies against N-methyl-D-aspartate receptor subunit NR1","volume":"79","author":"Castillo-Gomez","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2019.102348_bb0685","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ana.23794","article-title":"Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy","volume":"73","author":"Querol","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2019.102348_bb0690","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.schres.2015.01.009","article-title":"N-methyl-d-aspartate receptor autoantibodies in schizophrenia and affective disorders","volume":"162","author":"Steiner","year":"2015","journal-title":"Schizophr Res"},{"key":"10.1016\/j.autrev.2019.102348_bb0695","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.devbrainres.2004.01.001","article-title":"GABAA receptor subunit mRNA expression in cultured embryonic and adult human dorsal root ganglion neurons","volume":"149","author":"Maddox","year":"2004","journal-title":"Dev Brain Res"},{"key":"10.1016\/j.autrev.2019.102348_bb0700","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1172\/JCI116024","article-title":"Myasthenia gravis. CD4+ T epitopes on the embryonic gamma subunit of human muscle acetylcholine receptor","volume":"90","author":"Protti","year":"1992","journal-title":"J Clin Investig"},{"key":"10.1016\/j.autrev.2019.102348_bb0705","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis","volume":"30","author":"Hughes","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.autrev.2019.102348_bb0710","first-page":"392","article-title":"Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors","volume":"12","author":"Omdal","year":"2005","journal-title":"Eur J Neurol Offl J Eur Fed Neurol Soc"},{"key":"10.1016\/j.autrev.2019.102348_bb0715","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ana.24233","article-title":"Immunoglobulin G antibodies to the N-methyl-D-aspartate receptor are distinct from immunoglobulin A and immunoglobulin M responses","volume":"77","author":"Lancaster","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2019.102348_bb0720","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.npbr.2016.01.008","article-title":"CSF diagnostics in psychiatry \u2013 present status \u2013 future projects","volume":"22","author":"Bechter","year":"2016","journal-title":"Neurol Psychiatry Brain Res"},{"key":"10.1016\/j.autrev.2019.102348_bb0725","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fpsyt.2017.00013","article-title":"Synaptic and neuronal autoantibody-associated psychiatric syndromes: controversies and hypotheses","volume":"8","author":"Al-Diwani","year":"2017","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.autrev.2019.102348_bb0730","doi-asserted-by":"crossref","first-page":"e0121364","DOI":"10.1371\/journal.pone.0121364","article-title":"Antibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxylase autoimmunity","volume":"10","author":"Gresa-Arribas","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.autrev.2019.102348_bb0735","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/nyas.12764","article-title":"Autoantibodies in movement and psychiatric disorders: updated concepts in detection methods, pathogenicity, and CNS entry","volume":"1351","author":"Sinmaz","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2019.102348_bb0740","doi-asserted-by":"crossref","first-page":"8151","DOI":"10.1523\/JNEUROSCI.4415-13.2014","article-title":"Identification and characterization of GABAA receptor autoantibodies in autoimmune encephalitis","volume":"34","author":"Ohkawa","year":"2014","journal-title":"J Neurosci"},{"key":"10.1016\/j.autrev.2019.102348_bb0745","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2019.102348_bb0750","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/eji.1830160206","article-title":"Limiting dilution analysis of the B cell compartment in human bone marrow","volume":"16","author":"Hibi","year":"1986","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2019.102348_bb0755","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.4049\/jimmunol.1301555","article-title":"Proteasome inhibition with bortezomib depletes plasma cells and specific autoantibody production in primary thymic cell cultures from early-onset myasthenia gravis patients","volume":"193","author":"Gomez","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2019.102348_bb0760","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/brain\/aws082","article-title":"Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis","volume":"135","author":"Bien","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2019.102348_bb0765","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40981-016-0048-3","article-title":"Anti-NMDA receptor encephalitis presenting as an acute psychotic episode misdiagnosed as dissociative disorder: a case report","volume":"2","author":"Shimoyama","year":"2016","journal-title":"J Clin Rep"},{"key":"10.1016\/j.autrev.2019.102348_bb0770","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s10072-017-2958-x","article-title":"Persistence of anti-NMDAR antibodies in CSF after recovery from autoimmune encephalitis","volume":"38","author":"Mariotto","year":"2017","journal-title":"Neurol Sci"},{"key":"10.1016\/j.autrev.2019.102348_bb0775","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/01.pra.0000428562.86705.cd","article-title":"Anti-NMDA receptor encephalitis: a cause of acute psychosis and catatonia","volume":"19","author":"Ryan","year":"2013","journal-title":"J Psychiatr Pract"},{"key":"10.1016\/j.autrev.2019.102348_bb0780","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.1097","article-title":"Potassium channel antibodies in two patients with reversible limbic encephalitis","volume":"50","author":"Buckley","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2019.102348_bb0785","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/WCO.0000000000000445","article-title":"Postviral autoimmune encephalitis: manifestations in children and adults","volume":"30","author":"Pruss","year":"2017","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.autrev.2019.102348_bb0790","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/S0140-6736(03)12983-2","article-title":"Amnesia, cerebral atrophy, and autoimmunity","volume":"361","author":"Schott","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2019.102348_bb0795","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/brain\/awh077","article-title":"Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis","volume":"127","author":"Vincent","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2019.102348_bb0800","doi-asserted-by":"crossref","DOI":"10.1192\/bjp.bp.105.012864","article-title":"Psychiatric presentation of voltage-gated potassium channel antibody-associated encephalopathy","volume":"189","author":"Parthasarathi","year":"2006","journal-title":"Br J Psychiatry J Mental Sci"},{"key":"10.1016\/j.autrev.2019.102348_bb0805","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1469-8749.2012.04249.x","article-title":"VGKC-complex antibody mediated encephalitis presenting with psychiatric features and neuroleptic malignant syndrome \u2013 further expanding the phenotype","volume":"54","author":"Anand","year":"2012","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.autrev.2019.102348_bb0810","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ana.410380505","article-title":"Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves","volume":"38","author":"Shillito","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2019.102348_bb0815","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.psychres.2012.03.008","article-title":"Dynamics of neurological soft signs and its relationship to clinical course in patients with first-episode schizophrenia","volume":"200","author":"Prikryl","year":"2012","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.autrev.2019.102348_bb0820","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.pra.0000445250.20875.0e","article-title":"Neurological soft signs discriminate schizophrenia from bipolar disorder","volume":"20","author":"Rigucci","year":"2014","journal-title":"J Psychiatr Pract"},{"key":"10.1016\/j.autrev.2019.102348_bb0825","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.schres.2009.01.023","article-title":"Increased antibodies for the alpha7 subunit of the nicotinic receptor in schizophrenia","volume":"109","author":"Chandley","year":"2009","journal-title":"Schizophr Res"},{"key":"10.1016\/j.autrev.2019.102348_bb0830","doi-asserted-by":"crossref","first-page":"e0208412","DOI":"10.1371\/journal.pone.0208412","article-title":"Alpha7 acetylcholine receptor autoantibodies are rare in sera of patients diagnosed with schizophrenia or bipolar disorder","volume":"13","author":"Hoffmann","year":"2018","journal-title":"PLoS One"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721930148X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721930148X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:16:14Z","timestamp":1761599774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156899721930148X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":166,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S156899721930148X"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2019.102348","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmunity in psychotic disorders. Where we stand, challenges and opportunities","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2019.102348","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102348"}}